ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,007Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 97

$927K Total Retail Price of All Prescriptions

Rank: 6 out of 97

705 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 705 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 705 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 13,835 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 817 762 1 2
LISINOPRIL 812 724 2 4
LEVOTHYROXINE SODIUM 754 626 3 1
AMLODIPINE BESYLATE 528 472 4 6
OMEPRAZOLE 501 399 5 5
METOPROLOL SUCCINATE 469 412 6 8
FUROSEMIDE 394 321 7 3
LOSARTAN POTASSIUM 387 341 8 13
METOPROLOL TARTRATE 333 284 9 7
WARFARIN SODIUM 333 286 9 11
HYDROCHLOROTHIAZIDE 313 275 11 9
POTASSIUM CHLORIDE 313 270 11 10
METFORMIN HCL 297 237 13 12
GABAPENTIN 210 160 14 18
ZOLPIDEM TARTRATE 195 106 15 32
CITALOPRAM HBR 187 159 16 20
HYDROCODONE-ACETAMINOPHEN 183 97 S3 17 17
CARVEDILOL 181 173 18 25
ATORVASTATIN CALCIUM 175 137 19 14
TRIAMTERENE-HCTZ 166 162 20 30
DIOVAN 160 156 21 44
ATENOLOL 158 133 22 15
CRESTOR 146 119 23 29
OXYCODONE HCL 143 39 S2 24 114
ISOSORBIDE MONONITRATE ER 142 129 25 27
ADVAIR DISKUS 137 96 26 40
TRAMADOL HCL 136 105 27 21
SPIRONOLACTONE 134 101 28 33
ZETIA 133 119 29 51
MIRTAZAPINE 131 123 30 35
MELOXICAM 129 116 31 87
ALLOPURINOL 129 121 31 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 111 33 36
DONEPEZIL HCL 125 125 34 24
JANUVIA 125 87 34 59
TAMSULOSIN HCL 124 116 36 31
PANTOPRAZOLE SODIUM 124 107 36 53
SERTRALINE HCL 119 114 38 16
FLUOXETINE HCL 116 79 39 63
GLIMEPIRIDE 115 89 40 39
NAMENDA 115 115 40 38
TRAZODONE HCL 113 87 42 42
PRAVASTATIN SODIUM 112 108 43 28
AMITRIPTYLINE HCL 111 88 R 44 54
FLUTICASONE PROPIONATE 110 71 45 52
METFORMIN HCL ER 109 78 46 89
LOSARTAN-HYDROCHLOROTHIAZIDE 106 88 47 49
DIGOXIN 97 97 48 26
ALENDRONATE SODIUM 96 89 49 19
CLOPIDOGREL 93 67 50 34
NEXIUM 90 46 51 66
PREDNISONE 87 78 52 23
LANTUS SOLOSTAR 86 56 53 41
GLIPIZIDE 86 86 53 78
PAROXETINE HCL 81 52 55 56
PROAIR HFA 80 35 56 76
SYNTHROID 74 44 57 108
HYDRALAZINE HCL 74 67 57 84
DILTIAZEM ER 72 72 59 85
PLAVIX 70 47 60 46
DILTIAZEM 24HR ER 68 64 61 69
DIOVAN HCT 67 67 62 135
FENTANYL 66 19 S2 63 50
CYCLOBENZAPRINE HCL 64 31 R 64 132
BENICAR 63 56 65 138
CLONIDINE HCL 63 49 65 72
POLYETHYLENE GLYCOL 3350 60 57 67 55
OXYCONTIN 59 0 S2 68 215
ESCITALOPRAM OXALATE 59 37 68 93
GLYBURIDE 58 58 R 70 75
CYMBALTA 57 42 71 80
SPIRIVA 55 54 72 48
BUPROPION XL 54 19 73 164
RANITIDINE HCL 54 42 73 67
VERAPAMIL ER 53 40 75 90
PEN NEEDLE 52 38 76 57
BYSTOLIC 52 52 76 99
SINGULAIR 50 32 78 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.